NCT00614848View on ClinicalTrials.gov

The ENDEAVOR II Clinical Trial: The Medtronic Endeavor Drug Eluting Coronary Stent System in Coronary Artery Lesions

NACompletedINTERVENTIONAL
Enrollment

1,200

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

January 31, 2005

Study Completion Date

July 31, 2009

Conditions
Coronary Artery DiseaseArterial Occlusive DiseasesCoronary DiseaseCoronary ArteriosclerosisHeart DiseasesMyocardial IschemiaVascular DiseasesIschemiaArteriosclerosis
Interventions
DEVICE

Endeavor drug eluting coronary stent

Zotarolimus coated coronary stent (10ug/mm)

Trial Locations (1)

Unknown

Dr. J. Fajedet, Clinique Pasteur

Sponsors

Lead Sponsor

Medtronic Vascular
All Listed Sponsors
lead

Medtronic Vascular

INDUSTRY